Oncotelic Therapeutics (OTLC) Non-Current Assets (2010 - 2026)
Oncotelic Therapeutics (OTLC) recorded Non-Current Assets of $393.29 million in Q2 2026, compared with $26.54 million a year earlier.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Oncotelic Therapeutics reported Non-Current Assets of $391.89 million.
- Annual Non-Current Assets has a five-year compound annual growth rate of 76.2% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $26.54 million in FY2024 (-10.8%), $29.74 million in FY2023 (-17.0%), $35.81 million in FY2022 (+55.8%) and $22.99 million in FY2021 (-0.3%).
- The Q2 2026 figure is the highest quarterly Non-Current Assets in data going back to Q4 2010.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 73.6% in Q3 2022, against a decline of 25.5% in Q2 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Oncotelic Therapeutics | 5.77 Mn | 4.94 Mn | - | 393.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 393.29 Mn |
| Dec 31, 2025 | 391.89 Mn |
| Sep 30, 2025 | 26.54 Mn |
| Jun 30, 2025 | 26.54 Mn |
| Mar 31, 2025 | 26.54 Mn |
| Dec 31, 2024 | 26.54 Mn |
| Sep 30, 2024 | 26.54 Mn |
| Jun 30, 2024 | 29.74 Mn |
| Mar 31, 2024 | 29.74 Mn |
| Dec 31, 2023 | 29.74 Mn |
| Sep 30, 2023 | 29.73 Mn |
| Jun 30, 2023 | 29.73 Mn |
| Mar 31, 2023 | 35.81 Mn |
| Dec 31, 2022 | 35.81 Mn |
| Sep 30, 2022 | 39.92 Mn |
| Jun 30, 2022 | 39.92 Mn |
| Mar 31, 2022 | 22.97 Mn |
| Dec 31, 2021 | 22.99 Mn |
| Sep 30, 2021 | 23.00 Mn |
| Jun 30, 2021 | 23.02 Mn |
API Access
Oncotelic Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();